Phase II study of capecitabine-based concomitant chemoradiation followed by durvalumab as a neoadjuvant strategy in locally advanced rectal cancer: the PANDORA trial

Authors:

Abstract
No abstract available
Funding Information
  • AstraZeneca

This publication has 41 references indexed in Scilit: